Thailand discovered a total of 2,476 daily Covid-19 infections with 32 additional deaths in the past 24 hours, the Center for Covid-19 Situation Administration (CCSA) reported today, December 21st.
The fatalities were 19 men and 13 women with the most numbers recorded in Chiang Mai with 4. All of them were Thai nationals. The age range was between 26 and 99 years old.
Most of them were reported with underlying health conditions, including hypertension (17), diabetes (8), hyperlipidemia (6), obesity (2), and kidney disease (4). One of the fatalities was a bedridden patient.
Of the new cases, 2,358 were found in hospitals and medical services (which includes contact tracing cases), 41 were from a proactive approach at previously reported clusters, 47 were from prisons, and the remaining 30 were imported cases.
A number of 38,892 patients are still under treatment/isolation/medical care. Of that, 880 patients are in critical condition including 237 on ventilators. This is roughly 2.26 percent of cases that are critical while 26.9 percent of that is critical enough for a ventilator.
Regarding the non-prison local infections, the highest number of patients were reported in Bangkok with 559, followed by Chonburi with 174, Nakhon Sri Thammarat with 114, Samut Prakan with 96, Songkhla with 85, and Chiang Mai with 65.
A total number of 273,326 people nationwide have received Covid-19 vaccines in the past 24 hours. Of that, 50,876 people had received their first shots, 108,685 people had received their second shots, and 113,765 people had received their third shots. This is roughly 70.2% of the total Thai population who have had their first shot of a Covid-19 vaccine, 61.8% who have had a second shot and are fully vaccinated, and 7.1% have had a third booster shot.
As of today, 3,649 people fully recovered in the past 24 hours and have been released from field hospitals and quarantine centers. Thailand has now reached a total of 2,196,529 cases with 2,136,197 recoveries and a total of 21,408 deaths since the start of the pandemic.
Follow us on Facebook